Paper: Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich
Program: Oral and Poster Abstracts Type: Oral Session: 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Therapies for Mantle Cell Lymphoma Hematology Disease Topics & Pathways: Research, Clinical trials, Lymphomas, Clinical Research, B Cell lymphoma, Chemotherapy, Diseases, Treatment Considerations, Lymphoid Malignancies, Non-Biological therapies David John Lewis, MD 1 *, Mats Jerkeman, MD, PhD 2, Lexy Sorrell 3 *, David Wright 4 *, Ingrid
